8TEA
HCMV Pentamer in complex with CS2pt1p2_A10L Fab and CS3pt1p4_C1L Fab
Summary for 8TEA
| Entry DOI | 10.2210/pdb8tea/pdb |
| EMDB information | 41179 |
| Descriptor | Envelope protein UL128, Envelope glycoprotein UL130, UL131A, ... (7 entities in total) |
| Functional Keywords | virus, glycoprotein, antibody, viral protein |
| Biological source | Human betaherpesvirus 5 More |
| Total number of polymer chains | 7 |
| Total formula weight | 153857.88 |
| Authors | Goldsmith, J.A.,McLellan, J.S. (deposition date: 2023-07-05, release date: 2023-08-09, Last modification date: 2024-10-09) |
| Primary citation | Zehner, M.,Alt, M.,Ashurov, A.,Goldsmith, J.A.,Spies, R.,Weiler, N.,Lerma, J.,Gieselmann, L.,Stohr, D.,Gruell, H.,Schultz, E.P.,Kreer, C.,Schlachter, L.,Janicki, H.,Laib Sampaio, K.,Stegmann, C.,Nemetchek, M.D.,Dahling, S.,Ullrich, L.,Dittmer, U.,Witzke, O.,Koch, M.,Ryckman, B.J.,Lotfi, R.,McLellan, J.S.,Krawczyk, A.,Sinzger, C.,Klein, F. Single-cell analysis of memory B cells from top neutralizers reveals multiple sites of vulnerability within HCMV Trimer and Pentamer. Immunity, 56:2602-2620.e10, 2023 Cited by PubMed Abstract: Human cytomegalovirus (HCMV) can cause severe diseases in fetuses, newborns, and immunocompromised individuals. Currently, no vaccines are approved, and treatment options are limited. Here, we analyzed the human B cell response of four HCMV top neutralizers from a cohort of 9,000 individuals. By single-cell analyses of memory B cells targeting the pentameric and trimeric HCMV surface complexes, we identified vulnerable sites on the shared gH/gL subunits as well as complex-specific subunits UL and gO. Using high-resolution cryogenic electron microscopy, we revealed the structural basis of the neutralization mechanisms of antibodies targeting various binding sites. Moreover, we identified highly potent antibodies that neutralized a broad spectrum of HCMV strains, including primary clinical isolates, that outperform known antibodies used in clinical trials. Our study provides a deep understanding of the mechanisms of HCMV neutralization and identifies promising antibody candidates to prevent and treat HCMV infection. PubMed: 37967532DOI: 10.1016/j.immuni.2023.10.009 PDB entries with the same primary citation |
| Experimental method | ELECTRON MICROSCOPY (3.4 Å) |
Structure validation
Download full validation report






